Structural and thermal characterization of glyceryl behenate by X-ray diffraction coupled to differential calorimetry and infrared spectroscopy

被引:80
作者
Brubach, J. B. [1 ]
Jannin, V.
Mahler, B.
Bourgaux, C.
Lessieur, P.
Roy, P.
Ollivon, M.
机构
[1] Synchrotron SOLEIL, F-91192 Gif Sur Yvette, France
[2] Gattefosse SAS, F-69804 St Priest, France
[3] Univ Nancy 1, UFR STMP, F-54506 Vandoeuvre Les Nancy, France
[4] Fac Pharm Chatenay Malabry, UMR 8612, Lab Physicochim Syst Polyphases, F-92296 Chatenay Malabry, France
关键词
excipient; solid dosage forms; lipids; glyceryl behenate; Compritol (R) 888 ATO; X-ray diffraction; differential scanning calorimetry;
D O I
10.1016/j.ijpharm.2006.11.057
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Physical and thermal properties of glyceryl behenate (Compritol((R)) 888 ATO) used as sustained-release, matrix in pharmaceutical applications are studied by coupled time-resolved synchrotron X-ray diffraction and Differential Scanning Calorimetry combined with Infrared Spectroscopy. With these techniques, all polymorphs formed. in glyceryl behenate, analyzed as received and after various thermal treatments from quenching to slow crystallization, are characterized. By using different well-controlled mixtures of mono-, di- and tribehenate, we identify each lamellar phase observed in the glyceryl behenate. Finally the influence of the crystallization rate on the formation of preferential conformations was also analyzed in order to bring insights into the polymorphism, of glyceryl behenate. By changing the crystallization rate of the sample, it was shown that one can favor the formation of preferential polymorphs in the sample. In particular the crystallization at 10 degrees C/min seems to be well adapted for producing a single lamellar phase with a period of 60.9 angstrom while a crystallization rate of 0.4 degrees C/min produces three different lamellar phases. (C) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:248 / 256
页数:9
相关论文
共 33 条
[1]
Compritol® 888 ATO:: an innovative hot-melt coating agent for prolonged-release drug formulations [J].
Barthelemy, P ;
Laforêt, JP ;
Farah, N ;
Joachim, J .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1999, 47 (01) :87-90
[2]
Structural and thermal characterization of mono- and diacyl polyoxyethylene glycol by infrared spectroscopy and X-ray diffraction coupled to differential calorimetry [J].
Brubach, JB ;
Ollivon, M ;
Jannin, V ;
Mahler, B ;
Bourgaux, C ;
Lesieur, P ;
Roy, P .
JOURNAL OF PHYSICAL CHEMISTRY B, 2004, 108 (46) :17721-17729
[3]
POLYMORPHISM OF GLYCERIDES [J].
CHAPMAN, D .
CHEMICAL REVIEWS, 1962, 62 (05) :433-&
[4]
CHAPMAN D, 1965, STRUCTURE LIPIDS SPE
[5]
DeJong S., 1978, ACTA CRYSTALLOGR B, VB34, P1570, DOI 10.1107/S0567740878006093
[6]
DI L, 1993, J LIPID RES, V34, P1611
[7]
X-ray and vibrational spectroscopic study on polymorphism of trielaidin [J].
Dohi, K ;
Kaneko, F ;
Kawaguchi, T .
JOURNAL OF CRYSTAL GROWTH, 2002, 237 (1-4 III) :2227-2232
[8]
EVIDENCE OF A PHASE-TRANSITION IN THE ROTATOR PHASE OF THE ODD-NUMBERED PARAFFINS C23H48 AND C25H52 [J].
DOUCET, J ;
DENICOLO, I ;
CRAIEVICH, A ;
COLLET, A .
JOURNAL OF CHEMICAL PHYSICS, 1981, 75 (10) :5125-5127
[9]
Hot-melt coating technology. I. Influence of compritol 888 Ato and granule size on theophylline release [J].
Faham, A ;
Prinderre, P ;
Farah, N ;
Eichler, KD ;
Kalantzis, G ;
Joachim, J .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2000, 26 (02) :167-176
[10]
Faham A, 2000, PHARMAZIE, V55, P444